Back to top
more

Thermo Fisher Scientific (TMO)

(Real Time Quote from BATS)

$605.09 USD

605.09
157,752

-10.60 (-1.72%)

Updated Aug 5, 2024 10:04 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Pacific Biosciences Hurt by Competition in Niche Markets

Pacific Biosciences (PACB) faces cutthroat competition in the niche space. Also, sluggishness in the European markets is a concern.

    Mark Vickery headshot

    Top Research Reports for Microsoft, Intel & UnitedHealth

    Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Intel (INTC) and UnitedHealth (UNH).

      Thermo Fisher Buys Phenom-World, Aids Analytical Instruments

      On completion of Phenom-World purchase, Thermo Fisher (TMO) plans to integrate the business into its Analytical Instruments segment.

        Can AngioDynamics (ANGO) Pull a Surprise in Q2 Earnings?

        AngioDynamics (ANGO) to gain from solid product portfolio and demand for Solero MTA system. However, unfavorable estimates are a concern.

          Global In Vitro Diagnostic Market Booms: Stocks in Focus

          With the emergence of complex and transmittable diseases worldwide, In Vitro Diagnostic within the MedTech space is currently in the spotlight.

            IDEXX Laboratories (IDXX) Q3 Earnings Beat, Revenues Miss

            IDEXX Laboratories (IDXX) rides high on strength in Companion Animal Group business in Q3. Moreover, a raised guidance buoys optimism.

              Luminex (LMNX) Tops Q3 Earnings, Meets Revenue Estimates

              Luminex's (LMNX) third quarter saw a strong top line, solid cash flow as well as profits in Q3. The company's Assay business is likely to drive growth over the long term.

                Thermo Fisher (TMO) Q3 Earnings & Sales Top, Guidance Up

                On solid third-quarter performance, a favorable foreign exchange environment and the recently closed acquisition of Patheon, Thermo Fisher (TMO) has raised its full-year 2017 guidance.

                  Thermo Fisher (TMO) Beats on Q3 Earnings & Sales Estimates

                  Thermo Fisher (TMO) rides high in Q3 banking on its analytical instruments segment in particular.

                    MedTech Stocks (BAX, VAR, TMO, LH) Earnings Preview: What You Should Know

                    The Medical Product space has been a precarious game for the Republicans since day one, courtesy of President Trump's repeated failure to repeal and replace Obamacare.

                      PetMed (PETS) Tops Q2 Earnings & Sales Estimates, Margins Up

                      The year-over-year rise in earnings of PetMed (PETS) was driven by an increase in sales and improved margins.

                        Will S.E.T. Arm Drive Zimmer Biomet's (ZBH) Q3 Earnings?

                        Zimmer Biomet (ZBH) poised to gain on strength in S.E.T as well as Spine & CMF segments in Q3.

                          Why Thermo Fisher (TMO) Might Surprise This Earnings Season

                          Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

                            Henry Schein (HSIC) Q3 Earnings to Show Growth in All Lines

                            Henry Schein (HSIC) likely to gain on strength across all business segments in Q3.

                              What's in Store for Penumbra (PEN) Stock in Q3 Earnings?

                              Penumbra (PEN) is expected to gain from strong performance by its neuro and peripheral vascular arms in Q3.

                                Can Companion Animal Group Drive IDEXX's (IDXX) Q3 Earnings?

                                IDEXX Laboratories (IDXX) is poised to gain from strength in its Companion Animal Group business in Q3.

                                  Will Invisalign Drive Align Technology's (ALGN) Q3 Earnings?

                                  Align Technology (ALGN) is poised to gain from strength in the Invisalign space in Q3.

                                    Will GNC Holdings (GNC) Disappoint This Earnings Season?

                                    Revenue growth at GNC Holdings (GNC) might remain sluggish on declining sales of protein, vitamins, weight management and food and drink categories in Q3.

                                      Quest Diagnostics (DGX) Beats Earnings in Q3, Updates View

                                      Despite hurricanes related financial impact, Quest Diagnostics (DGX) posted year-over-year growth in Q3 on recent acquisitions, tie-ups and strength in several advanced diagnostic offerings.

                                        Varian Medical (VAR) Initiates Halcyon Treatment in Europe

                                        Varian (VAR) has been taking initiatives to gain customers for its broad spectrum of products, especially targeting emerging markets.

                                          Abbott (ABT) Exceeds Q3 Earnings, '17 Guidance Narrowed

                                          Abbott (ABT) posted promising Q3 results primarily on the back of strong EPD sales and emerging market expansion.

                                            Will Recall Issue Hurt Boston Scientific (BSX) Q3 Earnings?

                                            Although Boston Scientific's (BSX) recent $435-million acquisition of Symetis SA might drive its IC business, the company's full recovery post a primary product recall may however, take time.

                                              What to Expect From Thermo Fisher (TMO) in Q3 Earnings

                                              Thermo Fisher (TMO) gears up for another quarter of strong analytical instruments segmental growth. Improvement is likely to be seen in applied markets too.

                                                Phibro Animal Banks on Diverse Portfolio, Competition Rife

                                                Phibro Animal (PAHC) is consistently trying to expand its product portfolio to counter the tough competition in the animal health space.

                                                  Henry Schein (HSIC) Inks Distribution Agreement with Terason

                                                  Henry Schein's (HSIC) distribution agreement with Terason to distribute the latter's uSmart 3200T NexGen is likely to boost its global Medical segment business.